Global Contrast Enhanced Ultrasound Market is set to capture over $2.6 Billion by 2030

Inkwood Research analyzed that the Global Contrast Enhanced Ultrasound Market is anticipated to record a 5.25% CAGR during the forecast period, 2022-2030.

VIEW TABLE OF CONTENT LINK - https://inkwoodresearch.com/reports/contrast-enhanced-ultrasound-market/#table-of-contents

Contrast enhanced ultrasound (CEUS) employs contrasting ultrasound media to traditional sonography used for medical purposes. Ultrasound contrast agents depend on different sound waves that are reflected between substances and interfaces. These reflections can be anything from a bubble surface to a complex structure. Compared to traditional ultrasound technologies, contrast enhanced ultrasounds are patient-friendly, radiation-free, and cost-efficient. Moreover, the increasing prevalence of liver, kidney, and vascular & gastrointestinal diseases globally is expected to propel the demand for contrast enhanced ultrasound services. In addition, the high demand for technologically advanced medical devices is anticipated to stimulate the growth of the global contrast enhanced ultrasound market during the forecast period.

REQUEST FREE SAMPLE LINK - https://inkwoodresearch.com/reports/contrast-enhanced-ultrasound-market/#request-free-sample

Technological Advancements propel Market Growth
Contrast enhanced ultrasound imaging is employed globally in many off-label and clinically approved applications. Cutting-edge technological advancements in this area, including contrast agent synthesis, device development, image processing techniques, design of novel pulse sequences, and the development of remote monitoring for ultrasound therapeutics, drive market growth.

The prevalence of chronic illnesses, including multimorbidity, is rising as the population ages. Further, urbanization quickens, the middle class expands, and individuals lead increasingly immobile lifestyles. As a result, the health systems are under pressure, and public health initiatives advise people to get regular screening exams to determine if they have certain chronic conditions, including cancer, diabetes, cardiovascular disease, etc. Therefore, the market is projected to grow in contrast-enhanced ultrasound diagnostic screenings.

Targeted Type set to Lead the Market
Therapeutic agents are either placed onto the contrast agent's shell or encapsulated in targeted-type contrast agents. The contrast agents release the active medicine as it reaches the target site, increasing bioavailability. This phenomenon is being extensively researched globally to determine how it might be used to treat serious diseases, including cancer and cardiovascular disease.

Additionally, several clinical investigations involving the delivery of DNA and nucleic acids using contrast-enhanced ultrasound technology have been completed. To boost its DNA binding affinity, one commercially available ultrasonic contrast agent named Definity has lengthened its chain and added charged radicals to its shell. As a result, the segment is expected to increase thanks to several potential targeted ultrasound agent progenies in the clinical and preclinical stages.

North America Expected to capture Highest Market Shares
Rising cases of chronic illness and the urgency for early diagnosis and detection propel the studied market toward growth. In North America, contrast-enhanced ultrasound is predominantly used in cardiac and abdominal imaging. Moreover, a rising number of training and education programs for radiologists regarding the diagnostic & therapeutic use of contrast-enhanced ultrasound is expected to boost the region's growth over the forecast period.

The market is highly fragmented due to numerous multinational and regional companies. The sector is dominated by a few players, accounting for the majority of the revenue. Competitive strategies employed by players include partnerships, mergers & acquisitions, and frequent launches of products with upgraded functions. Thus, the competitive rivalry in the market is likely to remain high during the forecast period.

Request for Customization: https://inkwoodresearch.com/request-for-custom-report/

Related Reports:

GLOBAL CARDIOVASCULAR ULTRASOUND MARKET - https://inkwoodresearch.com/reports/cardiovascular-ultrasound-market/

GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET - https://inkwoodresearch.com/reports/molecular-point-of-care-diagnostics-market/

GLOBAL VETERINARY DIAGNOSTICS MARKET - https://inkwoodresearch.com/reports/veterinary-diagnostics-market/

Inkwood Research
169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857)293-0150
Email: sales@inkwoodresearch.com
Website: www.inkwoodresearch.com

We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.

This release was published on openPR.